AMAndrea Marten

Andrea Marten

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Andrea Marten has a total of 73 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Different effects of prenatal air pollution exposure on cord blood protein profiles and postnatal lung function in infants born to asthmatic mothers

    by Carla Rebeca Da Silva Sena, Olga Gorlanova, Noëmi Künstle, Gabriela Martins Costa Gomes, Andrea Marten, Sven Schulzke, Florian Wyler, Vanessa E. Murphy, Paul D. Robinson, Peter D. Sly, et al.

  • Open Access

    ALARUM: Active One Health surveillance in LMICs to monitor and predict Antimicrobial Resistance Using Metagenomics – a cross-sectional study protocol

    by Marianne A B van der Sande, Daniel Valia, Caroline Tigoi, Nicole Stoesser, Linda Stamm, Andrea Marten, Bram Riems, Robert Musyimi, Yougbare Sibidou, Anita C Schurch, et al.

    Background: In rural sub-Saharan Africa (sSA), the burden of antimicrobial resistance (AMR) remains high. As AMR continues to rise, there is a strong need for practical, implementable surveillance to monitor and mitigate risks, as well as inform timely, evidence-based clinical decision-making. Emerging evidence points to possible community-level drivers, such as transmission between human, animal and environmental reservoirs as contributing factors, yet microbiological surveillance or opportunities for wastewater-based surveillance are often limited and insufficient in these settings. Therefore, alternative sustainable and affordable approaches are needed. We intend to build on the demonstrated potential of metagenomic profiling of pooled faecal material, which accurately predicted population-level AMR prevalence in invasive Enterobacterales infections. Methods and analysis: We aim to validate this metagenomic pooled approach on additional populations, and to evaluate whether AMR patterns could be similarly predicted from surveillance of community One Health reservoirs. We will assemble existing data from hospital-based microbiology diagnostic laboratories in rural Burkina Faso and Kenya, and determine to what extent community-level metagenomic data, and/or faecal material of patients on hospital admission, can predict AMR in clinical isolates. We will perform community-level surveys in eight clusters per country, randomly selecting 15 households per cluster. We will systematically sample suspected environmental AMR exposure sites in and around households (soil, drinking water, latrines, chicken faeces) and collect data on community-level antibiotic use, hygiene practices, contact with domestic animals and sanitary facilities. Samples and data will be collected twice: during the dry and during the rainy season. In addition to evaluating the accuracy of predicting resistance in clinical isolates, we will quantify community-level exposure risks. We will conduct metagenomic profiling on pooled DNA extracts from human stool samples (hospital and community-level) and from household environments. Bayesian statistical models will quantify relationships between AMR gene abundance in the environment and in human stool, and invasive bacteria identified among clinical patients, accounting for geography and seasonality. A cost-utility analysis will determine under what circumstances the use of pooled metagenomic data to inform empirical antibiotic policies would represent an efficient use of resources. Ethics and dissemination: The proposed surveillance protocol is developed in partnership with local communities and local and international researchers and has received ethical approval in Kenya and Burkina Faso. It will assess whether intermittent, pooled-sample metagenomics provides a viable, low-cost and practical approach for population-level AMR surveillance in settings that—like many in rural sSA—lack systematic microbiological diagnostics and where sewage systems for wastewater-based surveillance are absent. By providing an alternative to routine microbiological-based surveillance where this proves challenging to implement, this approach may help improve treatment outcomes, contribute to equity and public health. Findings will be disseminated through peer-reviewed publications and academic conferences and will contribute to the recently proposed WHO AMR surveillance strategy, which combines survey-based approaches with routine AMR surveillance.


  • Open Access

    Prenatal exposure to air pollution affects autophagy, senescence and remodelling proteins in cord blood

    by Olga Gorlanova, Heide Oller, Uri Nahum, Noëmi Künstle, Loretta Müller, Andrea Marten, Céline Rüttimann, Danielle Vienneau, Kees de Hoogh, Primo Schär, et al.

    Background: Air pollution increases inflammation and reactive oxygen species that can induce autophagy, thereby leading to airway inflammation and remodelling. However, it is unclear whether prenatal air pollution may impact proteins involved in autophagy. The objectives of the present study were to investigate the associations of prenatal air pollution with proteins indicative of autophagy, senescence and remodelling in infants. Methods: We included 387 healthy term newborns from the BILD cohort study and measured 11 proteins: interleukin (IL)-1β, IL-8, matrix metallopeptidase (MMP)-3, MMP-9, platelet-derived growth factor (PDGF)-AA, transforming growth factor-β (TGF-β), sirtuin-1, p62, LC3B, tumour necrosis factor-α (TNF-α), and Beclin-1 in cord blood serum and plasma. We assessed the association of whole pregnancy residential exposure to nitrogen dioxide (NO 2 ) and particulate matter (PM 10 ) with protein levels using multivariable Tobit regression models. We performed unsupervised hierarchical clustering based on protein concentrations with a network construction of identified clusters. Results: Our results indicate that NO 2 exposure during pregnancy can increase Beclin-1, a pivotal initiator of autophagy. Additionally, elevated NO 2 exposure was correlated with a reduction in IL-8 levels. Unsupervised hierarchical clustering of all measured proteins gave four distinct clusters with similar protein expression profiles. When analysing the clusters’ clinical and exposure characteristics, significant differences were observed in NO 2 and PM 10 exposure during pregnancy. Network analysis revealed distinct protein–protein correlation patterns among clusters. Conclusions: Our findings in healthy term newborns showed that prenatal air pollution exposure is associated with alterations in levels of autophagy-related proteins. For the first time, we identified four distinct clusters of newborns, suggesting that there are different air pollution response patterns in a healthy population.


  • Open Access

    Ultra-Sensitive Biosensors for Medical Applications Based on Nanomechanics: From Detection of Synthetic Biomolecules to Analysis of Sepsis in Pediatric Patients

    by François Huber, Hans Peter Lang, Andrea Marten, Julia Anna Bielicki, Ernst Meyer, Christoph Gerber

    Recent advancements in nanomechanical microcantilever biosensors open new possibilities for clinical applications, permitting precise analysis of molecular interactions. The technology enables tracking gene expression, molecular conformational changes, antibody binding and antibiotic resistance. In particular, hybridization of DNA or RNA extracted from biopsies and whole blood from patients has led to significant advancements in diagnostics of critical medical conditions, e.g., cancer, bacteraemia and sepsis, utilizing rapid, sensitive, and label-free detection. Direct diagnosis from patient samples is a decisive advantage over competitive methods circumventing elaborate and time-consuming purification, amplification and cultivation procedures prior to analysis. Here, recent developments are presented from simple DNA hybridization of synthesized oligonucleotides to RNA material obtained from patients’ blood samples, highlighting technological advancements in diagnostic applications, such as detection of pathogens and disease biomarkers. We envisage our method to be a significant input to rapid, early and sensitive diagnosis directly from patients’ blood without requirements for amplification or cultivation. This would represent a paradigm shift in diagnostics, as no competing method currently exists.


  • Open Access

    Borrelia burgdorferi infections in children and adolescents in Switzerland – a seroprevalence study 2023/2024 (BOBUINCA)

    by Laura Heeb, Nora Fritschi, Andrea Marten, Tatjana Welzel, Nicole Ritz, Ulrich Heininger

    Background: Lyme borreliosis is one of the most prevalent tick-borne diseases in Europe. Studies on seroprevalence of Borrelia burgdorferi IgG antibodies in children are rare. The aim of this study was to determine the seroprevalence of B. burgdorferi IgG antibodies in children and adolescents residing in North-Western Switzerland and neighbouring countries. Methods: Prospective cross-sectional observational single-centre study using left-over plasma of asymptomatic paediatric patients. Included were children aged 1–17 years living in North-Western Switzerland and bordering areas of France and Germany. Excluded were children with symptoms of Lyme borreliosis or a chronic disease possibly affecting plasma antibodies (immunodeficiency syndrome, systemic lupus erythematosus) or with such medication (e.g., intravenous immunoglobuline treatment, allogenic stem cell transplantation, immunosuppressive treatment) as well as refugees seeking asylum. IgG antibodies against B. burgdorferi were measured by ELISA and positive or borderline results by line blot. Positivity was defined as scenario 1: ELISA positive/line blot positive or borderline OR ELISA borderline/line blot positive. Scenario 2: ELISA positive or borderline/line blot positive. A multivariable logistic regression model for seropositivity was applied. Results: 962 children were included (mean age 9.63 years, standard deviation 5.01, 54.5% males). Seroprevalence for scenario 1 was 13.3% (95% CI: 11.2–15.6) and for scenario 2 11.2% (95% CI: 9.3–13.4). Seroprevalence (scenario 1) was comparable for age groups, sex and rural versus urban residence. Conclusion: This study shows an increased seroprevalence for B. burgdorferi in the paediatric age compared to previous childhood studies. We also found an increased risk for B. burgdorferi infection at young age.


  • Open Access

    Antibiotics in pregnancy influence nasal microbiome and respiratory morbidity in infancy

    by Céline Rüttimann, Annika Nissen-Kratzert, Nadja Mostacci, Noëmi Künstle, Andrea Marten, Amanda Gisler, Katharina Bacher, Sophie Yammine, Ruth Steinberg, Sven Schulzke, et al.

    Background: The effects of prenatal antibiotic exposure on respiratory morbidity in infancy and the involved mechanisms are still poorly understood. We aimed to examine whether prenatal antibiotic exposure in the third trimester is associated with nasal microbiome and respiratory morbidity in infancy and at school age, and whether this association with respiratory morbidity is mediated by the nasal microbiome.Methods: We performed 16S ribosomal RNA gene sequencing (regions V3–V4) on nasal swabs obtained from 296 healthy term infants from the prospective Basel–Bern birth cohort (BILD) at age 4–6 weeks. Information about antibiotic exposure was derived from birth records and standardised interviews. Respiratory symptoms were assessed by weekly telephone interviews in the first year of life and a clinical visit at age 6 years. Structural equation modelling was used to test direct and indirect associations accounting for known risk factors.Results: α-Diversity indices were lower in infants with antibiotic exposure compared to nonexposed infants (e.g.Shannon index p-value 0.006). Prenatal antibiotic exposure was also associated with a higher risk of any, as well as severe, respiratory symptoms in the first year of life (risk ratio 1.38, 95% CI 1.03–1.84; adjusted p-value (padj)=0.032 and risk ratio 1.75, 95% CI 1.02–2.97; padj=0.041, respectively), but not with wheeze or atopy in childhood. However, we found no indirect mediating effect of nasal microbiome explaining these clinical symptoms.Conclusion: Prenatal antibiotic exposure was associated with lower diversity of nasal microbiome in infancy and, independently of microbiome, with respiratory morbidity in infancy, but not with symptoms later in life.